Capricorn Fund Managers LTD Medicinova Inc Transaction History

Capricorn Fund Managers LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$2.01 - $2.6 $61,222 - $79,193	30,459 New	30,459 $63,000
Q1 2023 Apr 18, 2023	SELL	$1.95 - $2.54 $80,607 - $104,995	-41,337 Reduced 61.96%	25,379 $54,000
Q4 2022 Jan 17, 2023	BUY	$1.97 - $2.66 $131,430 - $177,464	66,716 New	66,716 $137,000
Q1 2022 May 10, 2022	SELL	$2.19 - $2.81 $117,603 - $150,897	-53,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.42 $140,157 - $237,354	53,700 New	53,700 $144,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Capricorn Fund Managers LTD with notifications on news.